AbTECH was established in September 1997 as a biotechnology company to focus on the use of growth factors in cancer diagnostic and therapy. It was incorporated in Paris as a regular registered company, "Société Anonyme". A first round of financing of $ 1.2 million has just been completed.
AbTECH objectives are threefold:
a. Conduct collaboration programs with academic labs:
- control respect of schedule and costs up to the anti-idiotypic mAb production,
- identify the most interesting external technologies to be used and the most qualified external teams to contract with in order to accelerate the program completion,
- negotiate subcontracting agreements with each team,
- coordinate the various teams,
- reassess and reorient team tasks, as necessary
b. Conduct in- and out-licensing negotiations on present and next proprietary technology.
c. Raise the necessary funding for preclinical development:
- setting up financial arrangement for development (Private Placement, Venture Capital, Public grants, pharmaceutical lab collaboration)
- setting up possible joint-ventures with industrial partners,
- managing the intellectual property portfolio.
| Contact Details: |
| 151, boulevard du Montparnasse |
| Paris |
| |
| 75006 |
| France |
| Tel: | 33(1) 55 42 17 00 |
| Fax: | 33(1) 55 42 17 01 |
| Email: | a.guedon@abtech.fr |
| WWW: | www.abtech.fr/

|
| |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 614 times since April 2007, the link to the organisation's website has been followed 134 times
Recent Search Terms used to find this page: ABTECH paris | ABTECH paris | ABTECH paris | .
Search for more companies in Paris
Search for more companies in
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
AbTECH